Inflammatory markers of symptomatic remission at 6 months in patients with first-episode schizophrenia
Abstract Neuroinflammation contributes to the pathophysiology of various mental illnesses including schizophrenia. We investigated peripheral inflammatory cytokines as a biomarker for predicting symptomatic remission in patients with first-episode schizophrenia. The study included 224 patients aged...
| Published in: | Schizophrenia |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2023-10-01
|
| Online Access: | https://doi.org/10.1038/s41537-023-00398-1 |